Mike Radford
Overview
Explore the profile of Mike Radford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barnes V, Cooke F, Harney N, Howe H, Katamine T, Molloy H, et al.
Vet Rec
. 2025 Jan;
196(1):38.
PMID: 39752012
No abstract available.
2.
Trees L, Heath M, Barnes V, Howe H, ONeill D, Packer R, et al.
Vet Rec
. 2023 Aug;
193(3):116-117.
PMID: 37539878
No abstract available.
3.
Crabb S, Griffiths G, Dunkley D, Downs N, Ellis M, Radford M, et al.
Eur Urol
. 2022 Jun;
82(5):512-515.
PMID: 35688662
The PI3K/AKT/PTEN pathway is frequently deregulated in metastatic castration-resistant prostate cancer (mCRPC). ProCAID was a phase 2 trial assessing addition of the AKT1/2/3 inhibitor capivasertib to docetaxel for patients with...
4.
Khoo S, FitzGerald R, Fletcher T, Ewings S, Jaki T, Lyon R, et al.
J Antimicrob Chemother
. 2021 Aug;
76(12):3286-3295.
PMID: 34450619
Objectives: AGILE is a Phase Ib/IIa platform for rapidly evaluating COVID-19 treatments. In this trial (NCT04746183) we evaluated the safety and optimal dose of molnupiravir in participants with early symptomatic...
5.
Griffiths G, FitzGerald R, Jaki T, Corkhill A, Reynolds H, Ewings S, et al.
Trials
. 2021 Jul;
22(1):487.
PMID: 34311777
Background: There is an urgent unmet clinical need for the identification of novel therapeutics for the treatment of COVID-19. A number of COVID-19 late phase trial platforms have been developed...
6.
Griffiths G, FitzGerald R, Jaki T, Corkhill A, Marwood E, Reynolds H, et al.
Trials
. 2020 Jun;
21(1):544.
PMID: 32560744
Objectives: Phase I - To determine the optimal dose of each candidate (or combination of candidates) entered into the platform. Phase II - To determine the efficacy and safety of...
7.
8.
Sonuga-Barke E, Barton J, Daley D, Hutchings J, Maishman T, Raftery J, et al.
Eur Child Adolesc Psychiatry
. 2017 Nov;
27(6):797-809.
PMID: 29086103
The objective of this study is to compare the efficacy and cost of specialised individually delivered parent training (PT) for preschool children with attention-deficit/hyperactivity disorder (ADHD) against generic group-based PT...
9.
Trill J, Simpson C, Webley F, Radford M, Stanton L, Maishman T, et al.
Trials
. 2017 Sep;
18(1):421.
PMID: 28886751
Background: Women with acute uncomplicated urine infection are usually treated with antibiotics. One trial has demonstrated that delayed antibiotic treatment offered without symptom relief results in a modest reduction in...
10.